BackgroundGallbladder cancer (GBC) is a mortal malignancy with limited therapeutic strategies. We aimed to develop novel immune scoring systems focusing on B7-H3. B7-H4. and HHLA2. https://www.roneverhart.com/Grace-Design-M801-MK2-High-Fidelity-p15168/